Relay Therapeutics RLAY
NASDAQ RLAY
$18.36 +0.67 (+3.79%)
At close: Sep 29, 2026 · 4:00 PM EDT

Relay Therapeutics (RLAY) Share-based Compensation (2019 - 2026)

Updated

Relay Therapeutics (RLAY) posted Share-based Compensation of $9.18 million for Q2 2026, down 36.7% from $14.5 million a year earlier and down 12.9% from the prior quarter.

Analysis

Relay Therapeutics (RLAY) Share-based Compensation (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Relay Therapeutics was $48.31 million, down 34.7% year-over-year; for FY2025, it came in at $62.42 million, down 33.7% from FY2024.

  • Annual Share-based Compensation shows a five-year compound annual growth rate of 14.3% (FY2020 to FY2025).
  • In prior years, Relay Therapeutics' Share-based Compensation was $94.14 million in FY2024 (+9.4%), $86.03 million in FY2023 (+53.2%), $56.14 million in FY2022 (+15.9%) and $48.45 million in FY2021 (+51.6%).
  • The Q2 2026 figure stands as the lowest quarterly Share-based Compensation since Q2 2020.
  • On a year-over-year basis, Share-based Compensation has declined in each of the last seven quarters, with an average decline of 27.4% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q1 2023, with growth of 59.9%; the weakest was Q2 2025, with a decline of 46.0%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $10.54 million (Q1 2026), $13.07 million (Q4 2025) and $15.53 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Relay Therapeutics 3.87 Bn 3.87 Bn - 9.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.18 Mn
Mar 31, 2026 10.54 Mn
Dec 31, 2025 13.07 Mn
Sep 30, 2025 15.53 Mn
Jun 30, 2025 14.50 Mn
Mar 31, 2025 19.33 Mn
Dec 31, 2024 17.64 Mn
Sep 30, 2024 22.48 Mn
Jun 30, 2024 26.83 Mn
Mar 31, 2024 27.19 Mn
Dec 31, 2023 19.27 Mn
Sep 30, 2023 21.84 Mn
Jun 30, 2023 23.41 Mn
Mar 31, 2023 21.52 Mn
Dec 31, 2022 13.82 Mn
Sep 30, 2022 13.72 Mn
Jun 30, 2022 15.15 Mn
Mar 31, 2022 13.46 Mn
Dec 31, 2021 10.22 Mn
Sep 30, 2021 12.42 Mn
API Access

Relay Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RLAY&period=max&api_key=YOUR_API_KEY